Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
Negotiating the terms of a research collaboration can be a minefield. Life sciences attorney Lori…
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
This month’s €6B acquisition of the UK heavyweight GW Pharmaceuticals by Jazz Pharmaceuticals has been…
While getting funding from a star investor can be great for business, many biotech entrepreneurs…
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
The public's response has been cautious after the European Union unveiled a pharmaceutical strategy last…
Gene therapies for the rare blood clotting disorder hemophilia B have taken a step closer…
Biomedical companies face unique challenges when it comes to media communication. Crisis communication, in particular,…
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…